Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP1B1 | Q16678 | 10/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.35 |
| ▸ | CRHBP | P24387 | 1/20 | 0.34 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30170061 | 0.93 | CYP1A2 (0.51) | CYP1A2CYP1B1ALDH1A1MAPK1KDM4E | |
| SCHEMBL959783 | 0.93 | CYP1A2 (0.51) | CYP1A2CYP1B1ALDH1A1MAPK1KDM4E | |
| SCHEMBL21368134 | 0.88 | CYP1A2 (0.53) | CYP1A2CYP1B1ALDH1A1MAPK1KDM4E | |
| SCHEMBL13085390 | 0.87 | CYP1A2 (0.46) | CYP1A2CYP1B1ALDH1A1MAPK1KDM4E | |
| SCHEMBL13085294 | 0.87 | MAPK1 (0.45) | CYP1A2CYP1B1ALDH1A1MAPK1KDM4E | |
| SCHEMBL4076119 | 0.84 | ENPP1 (0.42) | ALDH1A1MAPK1L3MBTL1PARP1ENPP1 | |
| SCHEMBL8097259 | 0.83 | CYP1A2 (0.49) | CYP1A2CYP1B1ALDH1A1MAPK1KDM4E | |
| SCHEMBL24067768 | 0.83 | CYP1A2 (0.43) | CYP1A2CYP1B1ALDH1A1KDM4EMAPT | |
| SCHEMBL14110179 | 0.83 | CYP1A2 (0.47) | CYP1A2CYP1B1ALDH1A1KDM4EMAPT | |
| SCHEMBL14110175 | 0.83 | CYP1A2 (0.47) | CYP1A2CYP1B1ALDH1A1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120234380-A1 | TERRYLENE COMPOUNDS, PREPARATION THEREOF AND USE THEREOF IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2012-09-20 | — | — | US | disclosed |
| US-20120234380-A1 | TERRYLENE COMPOUNDS, PREPARATION THEREOF AND USE THEREOF IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2012-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120234380-A1 | TERRYLENE COMPOUNDS, PREPARATION THEREOF AND USE THEREOF IN ORGANIC SOLAR CELLS | TTI1, C1S, CD4 | CYP1A2 294/4885CYP1B1 103/4885ALDH1A1 1813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.